WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 1 fonti

Study: Bio-interventional scleral reinforcement limits endothelial cell loss

WASHINGTON — A scleral reinforcement procedure resulted in minimal endothelial cell loss, according to a study presented at the American Society of Cataract and Refractive Surgery meeting. Arsham Sheybani, MD, ABO, presented data on the endothelial health of eyes that underwent bio-interventional scleral reinforcement of cyclodialysis cleft with CycloPen (Iantrek).

Raccontata dahealio.com

Timeline cronologica

  1. lunedì 15 giugno 2026·healio.com

    Study: Bio-interventional scleral reinforcement limits endothelial cell loss

    WASHINGTON — A scleral reinforcement procedure resulted in minimal endothelial cell loss, according to a study presented at the American Society of Cataract and Refractive Surgery…

  2. giovedì 18 giugno 2026·healio.com

    Cyclodialysis shows ‘remarkably high’ success rate across 120 years

    WASHINGTON — Cyclodialysis performed with modern ab interno approaches should not be discounted as a treatment option for glaucoma, according to a speaker. “The original surgery…